Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients

Acta Biochimica Polonica

Volumn 49, Issue 1, 2002, Pages 269-272

  Gackowski, Daniel ^a   Kruszewski, Marcin ^b,c   Banaszkiewicz, Zbigniew ^a   Jawien, Arkadiusz ^a   Olinski, Ryszard ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Colon cancer; Iron metabolism; Labile iron pool

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; BLOOD; CARCINOMA; COLON TUMOR; FEMALE; HUMAN; LYMPHOCYTE; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COLONIC NEOPLASMS; FEMALE; FERRITINS; HUMANS; IRON; LYMPHOCYTES; MALE; MIDDLE AGED; TRANSFERRIN;

EID: 0036048151     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2002_3845     Document Type: Article

References (14)

1. Halliwell, B.M. & Gutterige, J.M.C. (1999) Free Radicals in Biology and Medicine; 3rd edn. Oxford University Press Inc., New York.
2. Stevens, G., Graubard, B.I., Micozzi, M.S., Neriishi, K. & Blumberg, B.S. (1994) Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer 56, 364-369.
3. Nelson, R.L., Davis, F.G., Sutter, E., Sobin, L.H., Kikendall, J.W. & Bowen, P. (1994) Body iron stores and risk of colonic neoplasia. J. Natl. Cancer Inst. 86, 455-460.
4. Bird, C.L., Witte, J.S., Swendseid, M.E., Shikany, J.M., Hunt, I.F., Frankl, H.D., Lee, E.R, Longnecker, M.P. & Haile, R.W. (1996) Plasma ferritin, iron intake, and the risk of colorectal polyps. Am. J. Epidemiol. 144, 34-41.
5. Schmielau, J. & Finn, O.J. (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanisms of suppression of T-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760.
6. Gackowski, D., Ciecierski, M., Jawien, A. & Olinski, R. (2001) Background level of 8-oxo-2′-deoxyguanosine in lymphocyte DNA does not correlate with concentration of antioxidant vitamins in blood plasma. Acta Biochim. Polon. 48, 535-539.
7. Epsztejn, S., Kakhlon, O., Glickstein, H., Breuer, W. & Cabantchik, I. (1997) Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 248, 31-40.
8. 2. Blood 95, 2960-2966.
9. Stevens, R.G., Jones, D.Y., Micozzi, M.S. & Taylor, P.R. (1998) Body iron stores and the risk of cancer. N. Engl. J. Med. 319, 1047-1052.
10. Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliovaara, M. & Hakulinen, T. (1994) Body iron stores and risk of cancer. Int. J. Cancer 56, 379-382.
11. Bendich, A. & Cohen, M. (1990) Ascorbic acid safety: Analysis of factors affecting iron absorption. Toxicol. Lett. 51, 189-201.
12. Hallberg, L., Hulten, L. & Gramatkovski, E. (1997) Iron absorption from the whole diet in men: How effective is the regulation of iron absorption? Am. J. Clin. Nutr. 66, 347-356.
13. Ponka, P. (2000) Iron metabolism: Physiology and pathophysiology. J. Trace Elem. Exp. Med. 13, 73-93.
14. Weinberg, E.D. (1996) The role of iron in cancer. Eur. J. Cancer Prevent. 5, 19-36.